Attovia is headquartered at 1091 Industrial Road, Suite 310, San Carlos, California 94070
Attovia Therapeutics is incorporated in the state of Delaware
Attovia was founded and commenced operations in 2023
Attovia commenced trading on the NASDAQ stock exchange on August 5, 2026
Attovia’s fiscal year ends on December 31st
Attovia is traded on the NASDAQ stock exchange under the ticker symbol “ATTO”, and its CUSIP number is 04987L 102
Fidelity Stock Transfer℠ (FST)
Please contact Attovia’s transfer agent: Fidelity Stock Transfer℠ (FST)
PricewaterhouseCoopers LLP
Fenwick & West LLP
Attovia’s press release archives can be viewed here
- Attovia’s SEC filings can be viewed here
- Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov
You can submit inquiries to Attovia’s investor relations by contacting ir@attovia.com
